183 related articles for article (PubMed ID: 31416475)
1. Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis.
McCarty D; Gu Y; McIlveen JW; Lind BK
Addict Sci Clin Pract; 2019 Aug; 14(1):31. PubMed ID: 31416475
[TBL] [Abstract][Full Text] [Related]
2. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
[TBL] [Abstract][Full Text] [Related]
3. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
4. The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder.
Mojtabai R; Mauro C; Wall MM; Barry CL; Olfson M
Psychiatr Serv; 2019 Jul; 70(7):617-620. PubMed ID: 31035894
[TBL] [Abstract][Full Text] [Related]
5. Access to treatment for alcohol use disorders following Oregon's health care reforms and Medicaid expansion.
McCarty D; Gu Y; Renfro S; Baker R; Lind BK; McConnell KJ
J Subst Abuse Treat; 2018 Nov; 94():24-28. PubMed ID: 30243413
[TBL] [Abstract][Full Text] [Related]
6. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
[TBL] [Abstract][Full Text] [Related]
7. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.
Winkelman TNA; Ford BR; Shlafer RJ; McWilliams A; Admon LK; Patrick SW
PLoS Med; 2020 May; 17(5):e1003119. PubMed ID: 32421717
[TBL] [Abstract][Full Text] [Related]
8. The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.
Patton BP; Krans EE; Kim JY; Jarlenski M
Subst Abus; 2019; 40(3):371-377. PubMed ID: 30908175
[No Abstract] [Full Text] [Related]
9. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
10. The Medicaid expansion did not crowd out access for medicaid recipients with disabilities in Oregon.
Lindner S; Levy A; Horner-Johnson W
Disabil Health J; 2021 Apr; 14(2):101010. PubMed ID: 33419718
[TBL] [Abstract][Full Text] [Related]
11. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
[TBL] [Abstract][Full Text] [Related]
12. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
[TBL] [Abstract][Full Text] [Related]
13. Association of Medicaid Expansion With Access to Abortion Services for Women With Low Incomes in Oregon.
Harvey SM; Gibbs SE; Oakley LP
Womens Health Issues; 2021; 31(2):107-113. PubMed ID: 33168482
[TBL] [Abstract][Full Text] [Related]
14. Oregon Medicaid Expenditures After the 2014 Affordable Care Act Medicaid Expansion: Over-time Differences Among New, Returning, and Continuously Insured Enrollees.
Springer R; Marino M; O'Malley JP; Lindner S; Huguet N; DeVoe JE
Med Care; 2018 May; 56(5):394-402. PubMed ID: 29578955
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Medication Utilization for Opioid Use Disorder Among Medicaid-Insured HIV Patients in New York.
Choi S; Yerneni R; Healy S; Goyal M; Neighbors CJ
Am J Addict; 2020 Mar; 29(2):151-154. PubMed ID: 31951083
[TBL] [Abstract][Full Text] [Related]
16. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
[TBL] [Abstract][Full Text] [Related]
17. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
Pro G; Utter J; Haberstroh S; Baldwin JA
Drug Alcohol Depend; 2020 Apr; 209():107952. PubMed ID: 32172130
[TBL] [Abstract][Full Text] [Related]
18. Effect of expanding medicaid for parents on children's health insurance coverage: lessons from the Oregon experiment.
DeVoe JE; Marino M; Angier H; O'Malley JP; Crawford C; Nelson C; Tillotson CJ; Bailey SR; Gallia C; Gold R
JAMA Pediatr; 2015 Jan; 169(1):e143145. PubMed ID: 25561041
[TBL] [Abstract][Full Text] [Related]
19. Relationship of County Opioid Epidemic Severity to Changes in Access to Substance Use Disorder Treatment, 2009-2017.
Yarbrough CR; Abraham AJ; Adams GB
Psychiatr Serv; 2020 Jan; 71(1):12-20. PubMed ID: 31575353
[TBL] [Abstract][Full Text] [Related]
20. Receipt of Preventive Services After Oregon's Randomized Medicaid Experiment.
Marino M; Bailey SR; Gold R; Hoopes MJ; O'Malley JP; Huguet N; Heintzman J; Gallia C; McConnell KJ; DeVoe JE
Am J Prev Med; 2016 Feb; 50(2):161-70. PubMed ID: 26497264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
